Eris Lifesciences Ltd submitted a Confirmation Certificate under Regulation 74(5) of SEBI regulations for the quarter ended 30th September 2024, confirming the status of dematerialized securities. The securities received for dematerialisation were processed and listed correctly on stock exchanges.